Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.30 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17211987 | 0.81 | ALDH1A1 (0.45) | ALDH1A1TSHRTP53LMNAFGFR4 | |
| SCHEMBL20202274 | 0.81 | ALDH1A1 (0.45) | ALDH1A1TSHRTP53LMNAFGFR4 | |
| SCHEMBL560356 | 0.79 | ALDH1A1 (0.43) | ALDH1A1TSHRTP53LMNAFGFR4 | |
| SCHEMBL11801788 | 0.79 | ALDH1A1 (0.43) | ALDH1A1TSHRTP53LMNAFGFR4 | |
| SCHEMBL553887 | 0.77 | ALDH1A1 (0.41) | ALDH1A1TSHRTP53LMNAFGFR4 | |
| SCHEMBL4528380 | 0.75 | — | — | |
| SCHEMBL10380928 | 0.75 | — | — | |
| SCHEMBL12216199 | 0.74 | — | — | |
| SCHEMBL2554774 | 0.73 | ALDH1A1 (0.38) | ALDH1A1 | |
| Methacrylic Acid SCHEMBL30110651 | 0.73 | ALDH1A1 (0.38) | ALDH1A1TSHRTP53LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9744180-B2 | Pharmaceutical formulations containing mitochondrially targeted antioxidants | MITOTECH SA (LU) | 2017-08-29 | — | — | US | disclosed |
| US-9724313-B2 | Pharmaceutical composition for use in medical and veterinary ophthalmology | MITOTECH SA (LU) | 2017-08-08 | — | — | US | disclosed |
| US-20170128467-A1 | ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS WITH MULTIPLE DRUG RESISTANCE INHIBITING PROPERTIES | MITOTECH, S. A. (LU) | 2017-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170128467-A1 | ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS WITH MULTIPLE DRUG RESISTANCE INHIBITING PROPERTIES | SLC11A2, CFTR, ABCC1 | ALDH1A1 3272/4885TSHR 4214/4885TP53 3521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.